10-Q 1 nsys20200630_10q.htm FORM 10-Q nsys20200630_10q.htm
 
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-Q

 

(Mark One)

 

      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2020

 

OR

 

         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to          

 

NORTECH SYSTEMS INCORPORATED

 

Commission file number 0-13257

 

State of Incorporation: Minnesota

 

IRS Employer Identification No. 41-1681094

 

Executive Offices: 7550 Meridian Circle N., Suite # 150, Maple Grove, MN 55369

 

Telephone number: (952) 345-2244

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $.01 per share

NSYS 

NASDAQ Capital Market 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐

Accelerated Filer ☐

Non-accelerated Filer ☒

Smaller Reporting Company ☒

Emerging growth company ☐  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

 

Number of shares of $.01 par value common stock outstanding at August 7, 2020 was 2,657,530.

 

1

 

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION  
      PAGE
  Item 1 -   Financial Statements  
       
   

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) 

3
       
    Condensed Consolidated Balance Sheets  4
       
    Condensed Consolidated Statements of Cash Flows   5
       
    Condensed Consolidated Statements of Shareholders’ Equity  6
       
    Condensed Notes to Consolidated Financial Statements   7-18
       
  Item 2 -   Management's Discussion and Analysis of Financial Condition And Results of Operations 19-26
       
  Item 3 -   Quantitative and Qualitative Disclosures About Market Risk  26
       
  Item 4 -   Controls and Procedures 26
       
PART II - OTHER INFORMATION  
       
  Item 1 -   Legal Proceedings  27
       
  Item 1A. -   Risk Factors 27
       
  Item 2 -   Unregistered Sales of Equity Securities, Use of Proceeds  27
       
  Item 3 -   Defaults on Senior Securities  27
       
  Item 4 -   Mine Safety Disclosures 27
       
  Item 5 -   Other Information 27
       
  Item 6 -   Exhibits  28
       
SIGNATURES 29

  

2

 

 

PART

 

ITEM 1. FINANCIAL STATEMENTS

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME

(UNAUDITED)

(IN THOUSANDS, EXCEPT SHARE DATA)

 

   

THREE MONTHS ENDED

   

SIX MONTHS ENDED

 
   

JUNE 30,

   

JUNE 30,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Net Sales

  $ 26,461     $ 27,292     $ 53,901     $ 55,457  
                                 

Cost of Goods Sold

    24,020       24,967       48,455       50,171  
                                 

Gross Profit

    2,441       2,325       5,446       5,286  
                                 

Operating Expenses

                               

Selling Expenses

    730       797       1,351       1,558  

General and Administrative Expenses

    1,662       2,737       3,655       5,041  
                                 

Total Operating Expenses

    2,392       3,534       5,006       6,599  
                                 

Income (Loss) From Operations

    49       (1,209 )     440       (1,313 )
                                 

Other Expense

                               

Interest Expense

    (176 )     (279 )     (400 )     (524 )
                                 

(Loss) Income Before Income Taxes

    (127 )     (1,488 )     40       (1,837 )
                                 

Income Tax (Benefit) Expense

    (4 )     64       26       78  
                                 

Net (Loss) Income

  $ (123 )   $ (1,552 )   $ 14     $ (1,915 )
                                 

Net (Loss) Income Per Common Share - Basic

  $ (0.05 )   $ (0.58 )   $ 0.01     $ (0.72 )
                                 

Weighted Average Number of Common Shares Outstanding - Basic

    2,657,530       2,676,449       2,657,530       2,672,758  
                                 

Net (Loss) Income Per Common Share - Diluted

  $ (0.05 )   $ (0.58 )   $ 0.01     $ (0.72 )
                                 

Weighted Average Number of Common Shares Outstanding - Diluted

    2,657,530       2,676,449       2,666,532       2,672,758  
                                 

Other comprehensive loss

                               

Foreign currency translation

    19       (56 )     (42 )      

Comprehensive Loss, net of tax

  $ (104 )   $ (1,608 )   $ (28 )   $ (1,915 )

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

 

3

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS 

(IN THOUSANDS, EXCEPT SHARE DATA)

 

   

JUNE 30,

   

DECEMBER 31,

 
   

2020

    2019(1)  

 

 

(Unaudited)

         
ASSETS                

Current Assets

               

Cash

  $ 345     $ 351  

Restricted Cash

    409       309  

Accounts Receivable, less allowances of $391 and $335

    19,219       18,558  

Inventories

    15,492       14,279  

Contract Assets

    6,399       7,659  

Prepaid Expenses and Other Current Assets

    1,785       2,128  

Total Current Assets

    43,649       43,284  
                 

Property and Equipment, Net

    9,371       9,581  

Operating Lease Assets

    4,446       4,827  

Goodwill

    2,375       2,375  

Other Intangible Assets, Net

    1,237       1,343  

Total Assets

  $ 61,078     $ 61,410  
                 

LIABILITIES AND SHAREHOLDERS' EQUITY

               

Current Liabilities

               

Current Maturities of Long-Term Debt

  $ 444     $ 444  

Current Portion of Finance Lease Obligation

    643       557  

Current Portion of Operating Lease Obligations

    791       858  

Accounts Payable

    13,523       14,014  

Accrued Payroll and Commissions

    3,294       3,493  

Other Accrued Liabilities

    3,188       2,866  

Total Current Liabilities

    21,883       22,232  
                 

Long-Term Liabilities

               

Long Term Line of Credit

    4,392       10,088  

Long-Term Debt, Net

    9,046       3,179  

Long Term Finance Lease Obligation, Net

    1,486       1,451  

Long-Term Operating Lease Obligation, Net

    4,132       4,366  

Other Long-Term Liabilities

    116       118  

Total Long-Term Liabilities

    19,172       19,202  
                 

Total Liabilities

    41,055       41,434  
                 

Commitments and Contingencies

               
                 

Shareholders' Equity

               

Preferred Stock, $1 par value; 1,000,000 Shares Authorized: 250,000 Shares Issued and Outstanding

    250       250  

Common Stock - $0.01 par value; 9,000,000 Shares Authorized: 2,657,530 and 2,657,530 Shares Issued and Outstanding, respectively

    27       27  

Additional Paid-In Capital

    15,823       15,748  

Accumulated Other Comprehensive Loss

    (299 )     (257 )

Retained Earnings

    4,222       4,208  

Total Shareholders' Equity

    20,023       19,976  

Total Liabilities and Shareholders' Equity

  $ 61,078     $ 61,410  

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

The balance sheet at December 31, 2019 has been derived from the audited financial statements at that date

 

4

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(IN THOUSANDS)

 

   

SIX MONTHS ENDED

 
   

JUNE 30,

 
   

2020

   

2019

 

Cash Flows From Operating Activities

               

Net Income (Loss)

  $ 14     $ (1,915 )

Adjustments to Reconcile Net Income (Loss) to Net Cash

               

Provided by (Used In) Operating Activities

               

Depreciation and Amortization

    1,131       1,096  

Compensation on Stock-Based Awards

    75       191  

Change in Accounts Receivable Allowance

    56       40  

Change in Inventory Reserves

    (92 )     54  

Changes in Current Operating Items

               

Accounts Receivable

    (699 )     (646 )

Inventories

    (1,105 )     670  

Contract Assets

    1,260       (798 )

Prepaid Expenses and Other Current Assets

    357       (395 )

Income Taxes

    (117 )     -  

Accounts Payable

    (728 )     (1,087 )

Accrued Payroll and Commissions

    (610 )     596  

Other Accrued Liabilities

    930       (49 )

Net Cash Provided by (Used in) Operating Activities

    472       (2,243 )

Cash Flows from Investing Activities

               

Purchase of Intangible Asset

    (6 )     (25 )

Purchases of Property and Equipment

    (241 )     (545 )

Net Cash Used in Investing Activities

    (247 )     (570 )

Cash Flows from Financing Activities

               

Net Change in Line of Credit

    (5,696 )     3,469  

Proceeds from Long-term Debt

    6,077       -  

Principal Payments on Long-Term Debt

    (238 )     (584 )

Principal Payments on Finance Leases

    (274 )     (96 )

Stock Option Exercises

    -       7  

Share Repurchases

    -       (126 )

Net Cash (Used in) Provided By Financing Activities

    (131 )     2,670  
                 

Net Change in Cash

    94       (143 )

Cash - Beginning of Period

    660       948  
                 

Cash - Ending of Period

  $ 754     $ 805  
                 

Reconciliation of cash and restricted cash reported within the condensed consolidated balance sheets

               

Cash

  $ 345     $ 399  

Restricted Cash

    409       406  

Total cash and restricted cash reported in the condensed consolidated statements of cash flows

  $ 754     $ 805  
                 

Supplemental Disclosure of Cash Flow Information:

               

Cash Paid During the Period for Interest

  $ 394     $ 477  

Cash Paid and (Refunded) During the Period for Income Taxes

    72       (47 )
                 

Supplemental Noncash Investing and Financing Activities:

               

Property and Equipment Purchases in Accounts Payable

    237       180  

Equipment Acquired under Finance Lease

    395       -  

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

 

5

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(UNAUDITED)

(IN THOUSANDS)

 

                           

Accumulated

                 
                   

Additional

   

Other

   

 

   

Total

 
   

Preferred

   

Common

   

Paid-In

   

Comprehensive

    Retained    

Shareholders'

 
    Stock     Stock     Capital     Loss     Earnings     Equity  
                                                 

BALANCE MARCH 31, 2019

  $ 250     $ 27     $ 15,757     $ (177 )   $ 5,073     $ 20,930  

Net Loss

    -       -       -       -       (1,552 )     (1,552 )

Foreign currency translation adjustment

    -       -       -       (56 )     -       (56 )

Compensation on stock-based awards

    -       -       38       -       -       38  

Share repurchases

    -       -       (113 )     -       -       (113 )
                                                 

BALANCE JUNE 30, 2019

  $ 250     $ 27     $ 15,682     $ (233 )   $ 3,521     $ 19,247  
                                                 

BALANCE DECEMBER 31, 2018

  $ 250     $ 27     $ 15,610     $ (233 )   $ 5,436     $ 21,090  

Net Loss

    -       -       -       -       (1,915 )     (1,915 )

Foreign currency translation adjustment

    -       -       -       -       -       -  

Stock option exercises

    -       -       7       -       -       7  

Compensation on stock-based awards

    -       -       191       -       -       191  

Share repurchases

    -       -       (126 )     -       -       (126 )
                                                 

BALANCE JUNE 30, 2019

  $ 250     $ 27     $ 15,682     $ (233 )   $ 3,521     $ 19,247  
                                                 
                                                 

BALANCE MARCH 31, 2020

  $ 250     $ 27     $ 15,787     $ (318 )   $ 4,345     $ 20,091  

Net Loss

    -       -       -       -       (123 )     (123 )

Foreign currency translation adjustment

    -       -       -       19       -       19  

Compensation on stock-based awards

    -       -       36       -       -       36  
                                                 

BALANCE JUNE 30, 2020

  $ 250     $ 27     $ 15,823     $ (299 )   $ 4,222     $ 20,023  
                                                 

BALANCE DECEMBER 31, 2019

  $ 250     $ 27     $ 15,748     $ (257 )   $ 4,208     $ 19,976  

Net Income

    -       -       -       -       14       14  

Foreign currency translation adjustment

    -       -       -       (42 )     -       (42 )

Compensation on stock-based awards

    -       -       75       -       -       75  
                                                 

BALANCE JUNE 30, 2020

  $ 250     $ 27     $ 15,823     $ (299 )   $ 4,222     $ 20,023  

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

 

6

 

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
(UNAUDITED)

 

 

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements for the interim periods have been prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements, although we believe the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year or for any other interim period. In our opinion, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.

 

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In preparing these condensed consolidated financial statements, we have made our best estimates and judgments of certain amounts included in the condensed consolidated financial statements, giving due consideration to materiality. Changes in the estimates and assumptions used by us could have a significant impact on our financial results, since actual results could differ from those estimates.

 

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Nortech Systems Incorporated and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition

Our revenue is comprised of product, engineering services and repair services. All revenue is recognized when the Company satisfies its performance obligation(s) under the contract by transferring the promised product or service to our customer either when (or as) our customer obtains control of the product or service, with the majority of our revenue being recognized over time including goods produced under contract manufacturing agreements and services revenue. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation. The majority of our contracts have a single performance obligation. Revenue is recorded net of returns, allowances and customer discounts. Our net sales for services were less than 10% of our total sales for all periods presented, and accordingly, are included in net sales in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from revenues) basis. Shipping and handling costs charged to our customers are included in net sales, while the corresponding shipping expenses are included in cost of goods sold.

 

7

 

Stock-Based Awards

Following is the status of all stock options as of June 30, 2020:

 

   

Shares

   

Weighted-

Average

Exercise

Price Per

Share

   

Weighted-

Average

Remaining

Contractual

Term

(in years)

   

Aggregate

Intrinsic Value
(in thousands)

 

Outstanding - January 1, 2020

    372,200     $ 3.85                  

Granted

    11,300       2.95                  

Exercised

    -                          

Cancelled

    (4,000 )     3.29                  

Outstanding - June 30, 2020

    379,500     $ 3.83       8.13     $ 218  

Exercisable - June 30, 2020

    182,240     $ 3.72       7.70     $ 119  

 

In May 2017, the shareholders approved the 2017 Stock Incentive Plan which authorized the issuance of 400,000 shares, an additional 50,000 shares were authorized in March 2020. There were 11,300 stock options granted during the six months ended June 30, 2020.

 

Total compensation expense related to stock options for the three months ended June 30, 2020 and 2019 was $36 and $38, respectively and $75 and $191 for the six months ended June 30, 2020 and 2019, respectively. As of June 30, 2020, there was $292 of unrecognized compensation which will vest over the next 2.69 years.

 

In November 2010, the Board of Directors adopted the Nortech Systems Incorporated Equity Appreciation Rights Plan (“2010 Plan”). The total number of Equity Appreciation Right Units (“Units”) that can be issued under the 2010 Plan shall not exceed an aggregate of 1,000,000 Units as amended and restated on March 11, 2015. During the six months ended June 30, 2019, there were 137,500 units granted. There were no units granted during the six months ended June 30, 2020.

 

Net Income (Loss) per Common Share 

For the three months ended June 30, 2020, all stock options are deemed to be antidilutive and therefore, were not included in the computation of incomer per common share amount. For the six months ended June 30 ,2020, stock options of 9,002 were included in the computation of diluted income per common share amount as their impact were dilutive. For both the three months and six months ended June 30, 2019, all stock options are deemed to be antidilutive and, therefore, were not included in the computation of loss per common share amount.

 

Restricted Cash

Cash and cash equivalents classified as restricted cash on our condensed consolidated balance sheets are restricted as to withdrawal or use under the terms of certain contractual agreements. The June 30, 2020 balance included lockbox deposits that are temporarily restricted due to timing at the period end. The lockbox deposits are applied against our line of credit the next business day. As of June 30, 2020, we had no outstanding letters of credit.

 

8

 

Accounts Receivable and Allowance for Doubtful Accounts

Credit is extended based upon an evaluation of the customer’s financial condition and, while collateral is not required, the Company periodically receives surety bonds that guarantee payment. Credit terms are consistent with industry standards and practices. The amounts of trade accounts receivable have been reduced by an allowance for doubtful accounts of $391 at June 30, 2020 and $335 at December 31, 2019.

 

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Costs include material, labor, and overhead required in the warehousing and production of our products. Inventory reserves are maintained for the estimated value of the inventories that may have a lower value than stated or quantities in excess of future production needs.

 

Inventories are as follows (in thousands):

 

   

June 30,

   

December 31,

 
   

2020

   

2019

 

Raw Materials

  $ 15,846     $ 15,245  

Work in Process

    628       479  

Finished Goods

    412       41  

Reserves

    (1,394 )     (1,486 )
                 

Total

  $ 15,492     $ 14,279  

 

9

 

Other Intangible Assets

Other intangible assets at June 30, 2020 and December 31, 2019 are as follows (in thousands):

 

           

June 30, 2020

 
           

Gross

                 
           

Carrying

   

Accumulated

   

Net Book

 
   

Years

   

Amount

   

Amortization

   

Value

 

Customer Relationships

    9     $ 1,302     $ 723     $ 579  

Trade Names

    3       100       100       -  

Intellectual Property

    20       814       203       611  

Patents

    7       47       -       47  

Totals

          $ 2,263     $ 1,026     $ 1,237  

 

           

December 31, 2019

 
           

Gross

                 
           

Carrying

   

Accumulated

   

Net Book

 
   

Years

   

Amount

   

Amortization

   

Value

 

Customer Relationships

    9     $ 1,302     $ 651     $ 651  

Intellectual Property

    3       100       95       5  

Trade Names

    20       814       183       631  

Patents

    7       56       -       56  

Totals

          $ 2,272     $ 929     $ 1,343  

 

Amortization expense for the three and six months ended June 30, 2020 was $47 and $98, respectively.

Estimated future annual amortization expense (not including projects in process) related to these assets is approximately as follows (in thousands):

 

Year

 

Amount

 

Remainder of 2020

  $ 93  

2021

    186  

2022

    185  

2023

    185  

2024

    113  

Thereafter

    428  

Total

  $ 1,190  

 

Impairment of Goodwill and Other Intangible Assets

In accordance with ASC 350, Goodwill and Other Intangible Assets, goodwill is not amortized but is required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. We test impairment annually as of October 1st. No events were identified during the six months ended June 30, 2020 that would require us to test for impairment. In testing goodwill for impairment, we perform a quantitative impairment test, including computing the fair value of the reporting unit and comparing that value to its carrying value. If the fair value is less than it carrying value, then the goodwill is determined to be impaired. In the event that goodwill is impaired, an impairment charge to earnings would become necessary.

 

10

 

Impairment Analysis

We evaluate long-lived assets, primarily property and equipment and intangible assets, as well as the related depreciation periods, whenever current events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability for assets to be held and used is based on our projection of the undiscounted future operating cash flows of the underlying assets. To the extent such projections indicate that future undiscounted cash flows are not sufficient to recover the carrying amounts of related assets, a charge might be required to reduce the carrying amount to equal estimated fair value. No impairment expense was recorded during the three and six months ended June 30, 2020 and 2019.

 

Accounting Pronouncements Issued But Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments,” which amends the guidance on the impairment of financial instruments. The amendments in this update removes the thresholds that entities apply to measure credit losses on financial instruments measured at amortized cost, such as loans, trade receivables, reinsurance recoverables, off-balance-sheet credit exposures, and held-to-maturity securities. Under current U.S. GAAP, entities generally recognize credit losses when it is probable that the loss has been incurred. The guidance removes all current recognition thresholds and introduces the new current expected credit loss (“CECL”) model which will require entities to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that an entity expects to collect over the instrument’s contractual life. The new CECL model is based upon expected losses rather than incurred losses. The amendments in this update are effective for periods beginning after December 15, 2022; early adoption is permitted. We are currently evaluating the impact of this guidance on our financial condition and results of operations.

 

 

NOTE 2. CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

 

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. With regard to cash, we maintain our excess cash balances in checking accounts at primarily two financial institutions, one in the United States and one in China. The account in the United States may at times exceed federally insured limits. Of the $754 in cash at June 30, 2020, approximately $318 was held at banks located in China. We grant credit to customers in the normal course of business and do not require collateral on our accounts receivable.

 

Our largest customer has two divisions that together accounted for 10% or more of our net sales during the three and six months ended June 30, 2020 and 2019. One division accounted for approximately 20% and 22% of net sales for the three and six months ended June 30, 2020, respectively, and approximately 21% and 22% for both the three and six months ended June 30, 2019, respectively. The other division accounted for approximately 3% and 2% of net sales for the three months and six ended June 30, 2020, respectively, and approximately 2% net sales for both the three and six months ended June 30, 2019, respectively. Together they accounted for approximately 23% and 24% of net sales for the three and six months ended June 30, 2020, respectively, and approximately 23% and 24% of net sales for the three and six months ended June 30, 2019, respectively. Accounts receivable from the customer at June 30, 2020 and December 31, 2019 represented approximately 40% and 36% of our total accounts receivable, respectively.

 

11

 

Export sales represented approximately 9% and 17% of net sales for the three months ended June 30, 2020 and 2019, respectively. Export sales represented 11% and 18% of net sales for the six months ended June 30, 2020 and 2019, respectively.

 

 

NOTE 3. REVENUE

 

Revenue recognition

Our revenue is comprised of product, engineering services and repair services. All revenue is recognized when the Company satisfies its performance obligation(s) under the contract by transferring the promised product or service to our customer either when (or as) our customer obtains control of the product or service, with the majority of our revenue being recognized over time including goods produced under contract manufacturing agreements and services revenue. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation. The majority of our contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances and customer discounts. Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from revenues) basis. Shipping and handling costs are included in cost of goods sold.

 

The majority of our revenue is derived from the transfer of goods produced under contract manufacturing agreements which have no alternative use and we have an enforceable right to payment for our performance completed to date. Our performance obligations within our contract manufacturing agreements are generally satisfied over time as the goods are produced based on customer specifications and we have an enforceable right to payment for the goods produced. If these requirements are not met, the revenue is recognized at a point in time, generally upon shipment. Revenue under contract manufacturing agreements that was recognized over time accounted for approximately 84.6% and 86.1% of our revenue for both the three and six months ended June 30, 2020, respectively. Revenues under these agreements are generally recognized over time using an input measure based upon the proportion of actual costs incurred.

 

Accounting for contract manufacturing agreements involves the use of various techniques to estimate total revenue and costs. We estimate profit on these agreements as the difference between total estimated revenue and expected costs to complete the performance obligation within the terms of the agreement and recognize the respective profit as the goods are produced. The estimates to determine the profit earned on the performance obligation are based on anticipated selling prices and historical cost of goods sold and represent our best judgement at the time. Changes in judgements on these above estimates could impact the timing and amount of revenue recognized with a resulting impact on the timing and amount of associated profit.

 

On occasion our customers provide materials to be used in the manufacturing process and the fair value of the materials is included in revenue as noncash consideration at the point in time when the manufacturing process commences along with the same corresponding amount recorded as cost of goods sold. The inclusion of noncash consideration has no impact on overall profitability.

 

12

 

Contract Assets

Contract assets, recorded as such in the Condensed Consolidated Balance Sheet, consist of unbilled amounts related to revenue recognized over time. Significant changes in the contract assets balance during the six months ended June 30, 2020 was as follows (in thousands):

 

Six Months Ended June 30, 2020

       

Outstanding at January 1, 2020

  $ 7,659  

Increase (decrease) attributed to:

       

Transferred to receivables from contract assets recognized

    (6,277 )

Product transferred over time

    5,017  

Outstanding at June 30, 2020

  $ 6,399  

 

We expect substantially all the remaining performance obligations for the contract assets recorded as of June 30, 2020, to be transferred to receivables within 90 days, with any remaining amounts to be transferred within 180 days. We bill our customers upon shipment with payment terms of up to 120 days.

 

The following tables summarize our net sales by market for the three and six months ended June 30 (in thousands):

 

   

Three Months Ended June 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 11,464     $ 1,540     $ 367     $ 13,371  

Aerospace and Defense

    4,522       246       138       4,906  

Industrial

    6,395       1,593       196       8,184  

Total net sales

  $ 22,381     $ 3,379     $ 701     $ 26,461  

 

   

Three Months Ended June 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 13,145     $ 218     $ 661     $ 14,024  

Aerospace and Defense

    4,155       222       205       4,582  

Industrial

    7,428       878       380       8,686  

Total net sales

  $ 24,728     $ 1,318     $ 1,246     $ 27,292  

 

13

 

   

Six Months Ended June 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 25,084     $ 2,601     $ 1,048     $ 28,733  

Aerospace and Defense

    8,944       379       367       9,690  

Industrial

    12,390       2,563       525       15,478  

Total net sales

  $ 46,418     $ 5,543     $ 1,940     $ 53,901  

 

   

Six Months Ended June 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 27,640     $ 253     $ 1,070     $ 28,963  

Aerospace and Defense

    8,258       242       327       8,827  

Industrial

    15,568       1,475       624       17,667  

Total net sales

  $ 51,466     $ 1,970     $ 2,021     $ 55,457  

 

 

NOTE 4. FINANCING ARRANGEMENTS

 

We have a credit agreement with Bank of America which was entered into on June 15, 2017 and amended effective December 29, 2017 and provides for a line of credit arrangement of $16,000 that expires on June 15, 2022. The credit arrangement also has a $5,000 real estate term note outstanding with a maturity date of June 15, 2022.

 

Under the Bank of America credit agreement, both the line of credit and real estate term notes are subject to variations in the LIBOR rate. Our line of credit bears interest at a weighted-average interest rate of 3.2% and 5.8% as of June 30, 2020 and 2019, respectively. We had borrowings on our line of credit of $4,392 and $10,088 outstanding as of June 30, 2020 and December 31, 2019, respectively. There are no subjective acceleration clauses under the credit agreement that would accelerate the maturity of our outstanding borrowings.

 

The line of credit and real estate term notes with Bank of America contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.

 

The Bank of America Credit Agreement provides for, among other things, a Fixed Charge Coverage Ratio of not less than (i) 1.0 to 1.0, for the three months ending December 31, 2019, six months ending March 31, 2020, nine months ending June 30, 2020 and twelve months ending September 30, 2020 and each Fiscal Quarter end thereafter. The Company met the covenants for the period ended June 30, 2020.

 

The availability under the line is subject to borrowing base requirements, and advances are at the discretion of the lender. At June 30, 2020, we had unused availability under our line of credit of $8,311, supported by our borrowing base. The line is secured by substantially all of our assets.

 

14

 

On April 15, 2020, we entered into a Promissory Note with Bank of America, N.A. (the “Promissory Note”), which provides for an unsecured loan of $6,077 pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act and applicable regulations (the “CARES Act”) of which; funds were received on April 22, 2020. The Promissory Note has a term of 2 years with a 1% per annum interest rate. Payments are deferred for 10 months after the end of the Promissory Note covered period (which is defined as 24 weeks after the date of the loan) and we can apply for forgiveness of the Promissory Note after 60 days. Forgiveness of the Promissory Note will be determined in accordance with the provisions of the Cares Act and applicable regulations. Any principal and interest amounts outstanding after the determination of amounts forgiven will be repaid on a monthly basis.

 

Long-term debt at June 30, 2020 and December 30, 2019 consisted of following:

 

   

June 30,

   

December 31,

 
   

2020

   

2019

 

Real estate term notes bearing interest at one-month LIBOR + 2.25% (3.0% and 4.1% as of June 30, 2020 and December 31, 2019, respectively) maturing June 15, 2022 with monthly payments of approximately $41 plus interest secured by substantially all assets.

  $ 3,518     $ 3,755  
                 

Promissory Note

    6,077       -  
                 
      9,595       3,755  
                 

Debt issuance Costs

    (105 )     (132 )
                 

Total long-term debt

    9,490       3,623  

Current maturities of long-term debt

    (444 )     (444 )

Long-term debt - net of current maturities

  $ 9,046     $ 3,179  

 

15

 

 

NOTE 5. LEASES

 

We have operating leases for certain manufacturing sites, office space, and equipment. Most leases include the option to renew, with renewal terms that can extend the lease term from one to five years or more. Right-of-use lease assets and lease liabilities are recognized at the commencement date based on the present value of the remaining lease payments over the lease term which includes renewal periods we are reasonably certain to exercise. Our leases do not contain any material residual value guarantees or material restrictive covenants. At June 30, 2020, we do not have material lease commitments that have not commenced.

 

Supplemental balance sheet information related to leases was as follows:

 

 

Balance Sheet Location

 

June 30, 2020

 

Assets

         

Operating lease assets

Operating lease assets

  $ 4,446  

Finance lease assets

Property, Plant and Equipment

    2,842  

Total leased assets

  $ 7,288  
         

Liabilities

         

Current

         

Current operating lease liabilities

Current Portion of Operating Lease Obligations

    791  

Current finance lease liabilities

Current Portion of Finance Lease Obligations

    643  

Noncurrent

         

Long-term operating lease liabilities

Long Term Operating Lease Liabilities, Net

    4,132  

Long term finance lease liabilities

Long Term Finance Lease Obligations, Net

    1,486  

Total lease liabilities

  $ 7,052  

 

16

 

Supplemental cash flow information related to leases was as follows:

 

   

Three Months Ended June 30,

 
   

2020

 

Operating leases

       

Cash paid for amounts included in the measurement of lease liabilities

  $ 215  

Right-of-use assets obtained in exchange for lease obligations

  $  

 

Maturities of lease liabilities were as follows:

 

   

Operating

Leases

   

Finance Leases

   

Total

 

Remaining 2020

  $ 435     $ 391     $ 826  

2021

    722       738       1,460  

2022

    726       575       1,301  

2023

    738       333       1,071  

2024

    798       277       1,075  

Thereafter

    2,582       20       2,602  

Total lease payments

  $ 6,001     $ 2,334     $ 8,335  

Less: Interest

    (1,078

)

    (205 )     (1,283

)

Present value of lease liabilities

  $ 4,923     $ 2,129     $ 7,052  

 

The lease term and discount rate at June 30, 2020 were as follows:

 

Weighted-average remaining lease term (years)

       

Operating leases

    7.5  

Finance leases

    3.2  

Weighted-average discount rate

       

Operating leases

    4.8

%

Finance leases

    4.9

%

 

17

 

 

NOTE 6. INCOME TAXES

 

On a quarterly basis, we estimate what our effective tax rate will be for the full calendar year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three and six months ended June 30, 2020 was (3.2%) and 65.0%, respectively, and the rate for the three and six months ended June 30, 2019 was (4%).

 

 

NOTE 7. RELATED PARTY TRANSACTIONS

 

During three and six months ended June 30, 2020, we did business with Printed Circuits, Inc. which is 90% owned by the Kunin family, of which, owns a majority of our stock. We had expenses incurred totaling $14 and $0 during the three months ended June 30, 2020 and 2019, and $28 and $51 for the six months ended June 30, 2020 and 2019, respectively to Printed Circuits, Inc.

 

 

NOTE 8. SUBSEQUENT EVENTS

 

Sale and Leaseback Agreement

 

We have entered into sale and leaseback agreements with Essjay Investment Company, LLC (“Essjay”) relating to the Company’s manufacturing facilities in Bemidji and Mankato, Minnesota. Nortech and Essjay are expected to close during the Company’s fiscal third quarter, subject to final documentation and other customary closing conditions. 

 

The Company expects net proceeds from the sale, excluding expenses and expected taxes, of approximately $5,000. The Company intends to use net proceeds to pay down debt, provide additional liquidity for initiatives and strengthen the Company’s financial position. At closing, the Company will enter into a lease agreement for the Bemidji and Mankato, Minnesota facilities for an initial 15-year term, with multiple renewal options.

 

Facility Consolidation

 

To further improve operational efficiencies and lower overhead costs, the Company approved on August 7, 2020, the closure of our Merrifield, Minnesota, production facility, shifting wire and cable assembly, system-level assembly and printed circuit board (PCB) manufacturing to Nortech’s other Minnesota locations. The Merrifield production facility consolidation is expected to be complete on or before December 31, 2020, and will impact approximately 60 employees, who will be offered positions at other Nortech facilities in Minnesota.

 

18

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

We are a Maple Grove, Minnesota based full-service electronics manufacturing services (“EMS”) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to customers mainly in the aerospace and defense, medical, and industrial equipment markets. We maintain facilities in Bemidji, Blue Earth, Mankato, Merrifield, and Milaca, Minnesota; Monterrey, Mexico; and Suzhou, China. All of our facilities are certified to one or more of the ISO/AS standards, including 9001, AS9100 and 13485, with most having additional certifications based on the needs of the customers they serve.

 

Recent Developments

 

Global Pandemic

In March 2020, the World Health Organization recognized the outbreak of a novel coronavirus (“COVID-19”) as a pandemic. While the COVID-19 pandemic has had an impact on our operations, we have been able to continue to operate our manufacturing facilities and provide essential services to our customers. Additionally, in an effort to protect the health and safety of our employees and in compliance with state regulations, we have instituted a work-from-home policy for employees who can perform their job functions offsite, implemented social distancing requirements and other measures to allow manufacturing and other personnel essential to production to continue work within our manufacturing facilities, and suspended all non-essential employee travel.

 

The full extent to which COVID-19 will directly or indirectly impact our business, financial condition, and results of operations will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact and the economic impact on local, regional, national and international markets. We will continue to assess the potential impact of the COVID-19 pandemic on our business, financial condition, and results of operations.

 

Sale and Leaseback Agreement

We have entered into sale and leaseback agreements with Essjay Investment Company, LLC (“Essjay”) relating to the Company’s manufacturing facilities in Bemidji and Mankato, Minnesota.  Nortech and Essjay are expected to close during the Company’s fiscal third quarter, subject to final documentation and other customary closing conditions. 

 

The Company expects net proceeds from the sale, excluding expenses and expected taxes, of approximately $5 million.  The Company intends to use net proceeds to pay down debt, provide additional liquidity for initiatives and strengthen the Company’s financial position.  At closing, the Company will enter into a lease agreement for the Bemidji and Mankato, Minnesota facilities for an initial 15-year term, with multiple renewal options.

 

19

 

Results of Operations

 

The following table presents statements of operations data as percentages of total net sales for the periods indicated:

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2020

   

2019

   

2020

   

2019

 

Net Sales

    100.0

%

    100.0

%

    100.0

%

    100.0

%

Cost of Goods Sold

    90.8       91.5       89.9       90.5  

Gross Profit

    9.2       8.5       10.1       9.5  
                                 

Selling Expenses

    2.7       2.9       2.5       2.8  

General and Administrative Expenses

    6.3       10.0       6.8       9.1  

Income from Operations

    0.2       (4.4 )     0.8       (2.4 )
                                 

Other Expenses

    (0.7 )     (1.0 )     (0.7 )     (0.9 )

(Loss) Income Before Income Taxes

    (0.5 )     (5.4 )     0.1       (3.3 )
                                 

Income Tax Expense (Benefit)

    0.0       0.2       0.1       0.1  

Net (Loss) Income

    (0.5

)%

    (5.6

)%

    0.0

%

    (3.4

)%

 

Net Sales

 

Net sales were $26.5 million in the second quarter of 2020, as compared to $27.3 million in the second quarter of the prior year, a decrease of $0.8 million or 3.0%. Net sales results were varied by markets, the medical market decreased by $0.7 million or 4.7% with medical devices accounting for most of that decrease. Net sales from the aerospace and defense markets increased by $0.3 million or 7.1% in the second quarter of 2020 as compared to the second quarter of 2019. The industrial market decreased by $0.5 million or 5.8% of sales in the second quarter of 2020 as compared to the same quarter of 2019.

 

Net sales were $53.9 million in the six months ended 2020, as compared to $55.5 million in the prior year, a decrease of $1.6 million or 2.8%. Net sales results were varied by markets, the medical market decreased by $0.2 million, or 0.8%. Net sales from the aerospace and defense markets increased $0.9 million or 9.8%. The industrial market decreased by $2.2 million of sales or 12.4%

 

Net sales by our major EMS industry markets for the three and six months ended June 30, 2020 and 2019 were as follows (in thousands):

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2020

   

2019

   

%

   

2020

   

2019

   

%

 
    $     $    

Change

    $     $    

Change

 

Medical

    13,371       14,024       (4.7 )     28,733       28,963       (0.8 )

Aerospace and Defense

    4,906       4,582       7.1       9,690       8,827       9.8  

Industrial

    8,184       8,686       (5.8 )     15,478       17,667       (12.4 )

Total Net Sales

    26,461       27,292       (3.0 )     53,901       55,457       (2.8 )

 

20

 

Net sales by timing of transfer of goods and services for the three and six months ended June 30, 2020 is as follows (in thousands):

 

   

Three Months Ended June 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 11,464     $ 1,540     $ 367     $ 13,371  

Aerospace and Defense

    4,522       246       138       4,906  

Industrial

    6,395       1,593       196       8,184  

Total net sales

  $ 22,381     $ 3,379     $ 701     $ 26,461  

 

 

   

Six Months Ended June 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 25,084     $ 2,601     $ 1,048     $ 28,733  

Aerospace and Defense

    8,944       379       367       9,690  

Industrial

    12,390       2,563       525       15,478  

Total net sales

  $ 46,418     $ 5,543     $ 1,940     $ 53,901  

 

21

 

Net sales by timing of transfer of goods and services for the three and six months ended June 30, 2019 is as follows (in thousands):

 

   

Three Months Ended June 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 13,145     $ 218     $ 661     $ 14,024  

Aerospace and Defense

    4,155       222       205       4,582  

Industrial

    7,428       878       380       8,686  

Total net sales

  $ 24,728     $ 1,318     $ 1,246     $ 27,292  

 

 

   

Six Months Ended June 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 27,640     $ 253     $ 1,070     $ 28,963  

Aerospace and Defense

    8,258       242       327       8,827  

Industrial

    15,568       1,475       624       17,667  

Total net sales

  $ 51,466     $ 1,970     $ 2,021     $ 55,457  

 

Backlog

 

Our 90-day shipment backlog as of June 30, 2020 was $23.3 million, a decrease of 15.3% from the beginning of the quarter and a 25.8% decrease as compared to the prior year. Backlog for our medical customers has decreased 16.4% from the beginning of the quarter and decreased 28.2% from the prior year. The aerospace and defense backlog increased 1.3% from the beginning of the quarter and increased 1.0% from the prior year. Our industrial customers’ backlog decreased 30.7% from the beginning of the quarter and decreased 44.0% from the prior year. Our backlog consists of firm purchase orders we expect to ship in the next 90 days.

 

90-day shipment backlog by our major EMS industry markets are as follows (in thousands):

 

   

Shipment Backlog as of the Period Ended

 
   

June 30,

   

March 31,

   

June 30,

 
   

2020

   

2020

   

2019

 

Medical

  $ 11,987     $ 14,330     $ 16,701  

Aerospace and Defense

    6,900       6,812       6,833  

Industrial

    4,401       6,352       7,863  

Total Backlog

  $ 23,288     $ 27,494     $ 31,397  

 

22

 

Our 90-day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next. Our total shipment backlog was $46.6 million at June 30, 2020 compared to $58.7 million at the end of June 30, 2019.

 

Gross Profit

 

Gross profit as a percent of net sales for the three months ended June 30, 2020 and 2019 was 9.2% and 8.5%, respectively. Gross profit as a percentage of sales for the six months ended June 30, 2020 and 2019 was 10.1% and 9.5%, respectively. The increase in gross profit in both comparisons was driven by product mix.

 

Selling Expense

 

Selling expenses for the three months ended June 30, 2020 and 2019 was $0.7 million or 2.7% of sales and $0.8 million or 2.9% of sales, respectively. Selling expense for the six months ended June 30, 2020 and 2019 was $1.4 million or 2.5% of sales and $1.6 million or 2.8% of sales, respectively. The decrease in both the three and six month periods is due cost reduction measures taken in prior year.

 

General and Administrative Expense

 

General and administrative expenses for the three months ended June 30, 2020 and 2019 were $1.7 million or 6.3% of sales and $2.7 million or 10.0% of sales, respectively. General and administrative expenses for the six months ended June 30, 2020 and 2019 were $3.7 million or 6.8% of sales and $5.0 million or 9.1% of sales, respectively. The decrease in both comparisons was due to higher spend in the prior year related one-time expenditures to improve operations in 2019 and the benefits of those cost reduction measures in 2020.

 

Income / Loss from Operations

 

Second quarter 2020 Income from operations was $0.1 million compared to loss of $1.2 million for the second quarter in 2019. Income from operations for the first six months in 2019 was $0.4 million as compared to loss of $1.3 million for the same comparable period in 2019.  The increase in income from operations in both comparison periods was due to increased gross margin as a percent of sales and the decreased administrative expenses due to largely to cost reduction measures taken in the prior year.

 

Income Taxes

 

On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three and six months ended June 30, 2020 was (3.2%) and 65.0%, respectively, and the rate for the three and six months ended June 30, 2019 was (4%).

 

Net Income (Loss)

 

Net loss for the three and net income for the six months ended June 30, 2020 was $0.1 million and $0.0 million, respectively. Net loss for the three months ended June 30, 2019 was $1.6 million and for six month ended June 30, 2019 was $1.9 million.

 

23

 

Liquidity and Capital Resources

 

Our second quarter sales and shipment backlog were impacted by the COVID-19 pandemic. However, our focus on reducing costs, minimizing capital expenditures, and managing working capital mitigated the impact on liquidity. Due to the inherent uncertainty of this evolving situation, we are unable at this time to predict the likely impact of the COVID-19 pandemic on our future operations. However, we believe that cash provided by operations, funds available under the credit agreement with Bank of America, N.A. (BofA), funds available under a Promissory Note with BofA (“Promissory Note”) pursuant to the Paycheck Protection Program under the Coronavirus Aid and cash on hand will be adequate to meet our liquidity needs, including working capital, capital expenditures, and debt payment obligations.

 

Net cash provided by operating activities for the six months ended June 30, 2020 was $0.5 million. Earnings adjusted for depreciation and amortization of $1.1 million drove the cash provided offset by an increase in working capital.

 

Net cash used in operating activities for the six months ended June 30, 2019 was $2.2 million. The increase in accounts receivable and unbilled revenue and decrease in accounts payable drove this cash outflow, partially offset by a decrease in inventory.

 

We have satisfied our liquidity needs over the past several years with cash flows generated from operations and a bank operating line of credit. We have a credit agreement with BofA which was entered into on June 15, 2017 and amended on December 29, 2017 and provides for a line of credit arrangement of $16.0 million that expires on June 15, 2022. The credit arrangement also has a $5.0 million real estate term note outstanding with a maturity date of June 15, 2022.

 

Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit and real estate term notes with BofA contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.

 

On June 30, 2020, we had outstanding advances of $4.4 million under the line of credit and unused availability of $8.3 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $21.8 million and $21.1 million as of June 30, 2020 and December 31, 2019, respectively.

 

The Bank of America Credit Agreement provides for, among other things, a Fixed Charge Coverage Ratio of not less than (i) 1.0 to 1.0 for the three months ending December 31, 2019, six months ending March 31, 2020, nine months ending June 30, 2020 and twelve months ending September 30, 2020 and each fiscal quarter end thereafter. The Company met the covenants for the six months ended June 30, 2020.

 

On April 15, 2020, we entered into a Promissory Note, which provides for an unsecured loan of $6.1 million pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act and applicable regulations (the “CARES Act”) of which; funds were received on April 22, 2020. The Promissory Note has a term of 2 years with a 1% per annum interest rate. Payments are deferred for 10 months after the end of the Promissory Note covered period (which is defined as 24 weeks after the date of the loan) and we can apply for forgiveness of the Promissory Note after 60 days. Forgiveness of the Promissory Note will be determined in accordance with the provisions of the Cares Act and applicable regulations. Any principal and interest amount outstanding after the determination of amounts forgiven will be repaid on a monthly basis. We expect that all or a significant portion of the Promissory Note will be forgiven.

 

24

 

Off-Balance Sheet Arrangements

 

We have not engaged in any off-balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.

 

Critical Accounting Policies and Estimates

 

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2019. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.

 

Forward-Looking Statements

 

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.

 

 

Volatility in the marketplace which may affect market supply, demand of our products or currency exchange rates;

 

Increased competition from within the EMS industry or the decision of OEMs to cease or limit outsourcing;

 

Changes in the reliability and efficiency of our operating facilities or those of third parties;

 

Risks related to availability of labor;

 

Increases in certain raw material costs such as copper and oil;

 

Commodity and energy cost instability;

 

Risks related to FDA noncompliance;

 

The loss of a major customer;

 

General economic, financial and business conditions that could affect our financial condition and results of operations;

 

Increased or unanticipated costs related to compliance with securities and environmental regulation;

 

Disruption of global or local information management systems due to natural disaster or cyber-security incident;

 

Outbreaks of epidemic, pandemic, or contagious diseases, such as the recent novel coronavirus that affect our operations, our customers' operations or our suppliers' operations.

 

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Discussion of these factors is also incorporated in Part I, Item 1A, “Risk Factors,” and should be considered an integral part of Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

 

25

 

Please refer to forward-looking statements and risks as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

26

 

PART II

  

ITEM 1. LEGAL PROCEEDINGS

 

We are subject to various legal proceedings and claims that arise in the ordinary course of business.

 

ITEM 1A. RISK FACTORS

 

We are affected by the risks specific to us as well as factors that affect all businesses operating in a global market. The significant factors known to us that could materially adversely affect our business, financial condition or operating results or could cause our actual results to differ materially from our expectations are described in our annual report on Form 10-K for the fiscal year ended under the heading “Part I – Item 1A.Risk Factors.” Other than as noted below, there have been no material changes in the risk factors from those disclosed in the Annual Report on Form 10-K for the year ended December 31, 2019.

 

We may be subject to additional regulatory scrutiny in the form of an audit or review as a result of our Paycheck Protection Program Promissory Note which would have an adverse effect on our liquidity

On April 15, 2020, we entered into a Promissory Note with Bank of America, N.A. (the “Promissory Note”), which provides for an unsecured loan of $6.1 million pursuant to the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act and applicable regulations (the “CARES Act”) of which; funds were received on April 22, 2020. On April 23, 2020, the Small Business Administration (“SBA”) issued new guidance that questioned whether a public company with substantial market value and access to capital markets would qualify to participate in the PPP under the CARES Act. Subsequently, on April 28, 2020, the secretary of the Treasury and SBA announced that the government will review all PPP loans of more than $2 million for which a borrower applies for forgiveness. Should we be audited or reviewed by the U.S. Department of Treasury as a result of filing an application for forgiveness or otherwise, such audit or review could result in legal and reputational costs as well as significant use of management time. While the Company believes that it acted in good faith and has complied with all requirements of the PPP, if we are audited and receive an adverse or negative finding in such audit, we could be required to return up to the full amount of the Promissory Note, which would reduce our liquidity by such amount and potentially subject us to fines and penalties.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

As of June 30, 2020, our share repurchase program has expired, and no additional amounts are available for repurchase.

 

ITEM 3. DEFAULTS ON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

27

 

ITEM 6. EXHIBITS

 

Exhibits

 

  10.1* Purchase and Sale Agreement

 

  10.2* Second Quarter 2020 Earnings Release
     
 

31.1*

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.

 

 

31.2*

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.

 

 

32*

Certification of the Chief Executive Officer and Chief Financial Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

101*

Financial statements from the quarterly report on Form 10-Q for the quarter ended June 30, 2020, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations and Comprehensive Loss, (iii) Condensed Consolidated Statements of Cash Flows, and (iv) the Condensed Notes to Condensed Consolidated Financial Statements.

 

*Filed herewith

 

28

 

Signatures

-------------

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  Nortech Systems Incorporated and Subsidiaries  
  ---------------------------------------------------------  
       
       
Date: August 11, 2020   by /s/ Jay D. Miller  
       
    Jay D. Miller  
    Chief Executive Officer and President  
    Nortech Systems Incorporated  
       
Date: August 11, 2020    by /s/ Constance M. Beck  
       
    Constance M. Beck  
    Vice President and Chief Financial Officer  
    Nortech Systems Incorporated  

 

 

29